|
CDV3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.623800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.751300E-04 |
| Normal-vs-Stage2 |
3.579900E-02 |
| Normal-vs-Stage3 |
2.221800E-01 |
| Normal-vs-Stage4 |
5.398600E-01 |
| Stage1-vs-Stage2 |
7.560800E-01 |
| Stage1-vs-Stage3 |
2.327600E-01 |
| Stage1-vs-Stage4 |
6.723200E-01 |
| Stage2-vs-Stage3 |
5.001600E-01 |
| Stage2-vs-Stage4 |
7.969400E-01 |
| Stage3-vs-Stage4 |
9.276800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.563500E-03 |
| Normal-vs-AfricanAmerican |
1.190240E-02 |
| Normal-vs-Asian |
3.008600E-01 |
| Caucasian-vs-AfricanAmerican |
6.842400E-01 |
| Caucasian-vs-Asian |
7.084000E-01 |
| AfricanAmerican-vs-Asian |
8.056000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.358300E-04 |
| Normal-vs-Female |
4.903800E-01 |
| Male-vs-Female |
1.500080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.702100E-02 |
| Normal-vs-Extreme_Weight |
9.73770000000096E-05 |
| Normal-vs-Obese |
8.694200E-02 |
| Normal-vs-Extreme_Obese |
6.497800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.904800E-01 |
| Normal_Weight-vs-Obese |
4.249600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.920800E-01 |
| Extreme_Weight-vs-Obese |
4.442100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.338200E-01 |
| Obese-vs-Extreme_Obese |
8.935400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.543000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.667910E-02 |
| Normal-vs-Age(61-80Yrs) |
5.261300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.076200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.725800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.041400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.791600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.033800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.653200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.651200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.222100E-03 |
| Normal-VS-Type2 PRCC |
1.150170E-02 |
| Normal-VS-KIRP CIMP |
6.964300E-02 |
| Normal-VS-Unclassified PRCC |
1.200220E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.913400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.589100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.934800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.157090E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.446600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.919500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.70540000000408E-05 |
| Normal-vs-N1 |
5.100600E-01 |
| Normal-vs-N2 |
9.659400E-01 |
| N0-vs-N1 |
2.760500E-04 |
| N0-vs-N2 |
5.697000E-01 |
| N1-vs-N2 |
9.379800E-01 |
|
|
